{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:45:31Z","timestamp":1790999131375,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003752","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cooperative Research Center for Mental Health"},{"name":"Alzheimer's Australia Dementia Research Foundation"},{"name":"Melbourne Early Career Researcher Grants Scheme"},{"DOI":"10.13039\/501100002324","name":"Victorian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002324","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Operational Infrastructure Support Grant"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.nbd.2015.03.015","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T15:56:37Z","timestamp":1427385397000},"page":"168-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-1962","authenticated-orcid":false,"given":"Peng","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambili Thoppuvalappil","family":"Appukuttan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Volitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/acel.12178","article-title":"A novel approach to rapidly prevent age-related cognitive decline","volume":"13","author":"Adlard","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2015.03.015_bb0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nbd.2014.12.012","article-title":"Metal chaperones prevent zinc-mediated cognitive decline","volume":"81","author":"Adlard","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2015.03.015_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res."},{"issue":"8113","key":"10.1016\/j.nbd.2015.03.015_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(79)90928-0","article-title":"Clioquinol and S.M.O.N.: reanalysis of original data","volume":"1","author":"Asao","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2015.03.015_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","article-title":"Metallostasis in Alzheimer's disease","volume":"62","author":"Ayton","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0205","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-014-0312-z","article-title":"Biometals and their therapeutic implications in Alzheimer's disease","volume":"12","author":"Ayton","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.nbd.2015.03.015_bb0300","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1523\/JNEUROSCI.3439-14.2015","article-title":"Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein","volume":"35","author":"Ayton","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0265","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.neurobiolaging.2014.10.026","article-title":"Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A\/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging","volume":"36","author":"Bar-Am","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0245","doi-asserted-by":"crossref","first-page":"A193-A193","DOI":"10.1096\/fasebj.20.4.A193-d","article-title":"Reductions in the labile iron pool activate PKC and alter monoamine metabolism","volume":"20","author":"Beard","year":"2006","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0185","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","article-title":"The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons","volume":"56","author":"Ben-Shachar","year":"1991","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0125","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-06-3546","article-title":"Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper\u2013zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"issue":"8753","key":"10.1016\/j.nbd.2015.03.015_bb0225","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2015.03.015_bb9000","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","article-title":"Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice","volume":"114","author":"Dawson","year":"2001","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.canlet.2008.06.011","article-title":"Zinc-binding compounds induce cancer cell death via distinct modes of action","volume":"271","author":"Ding","year":"2008","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.nbd.2015.03.015_bb0285","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer's disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.nbd.2015.03.015_bb0250","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-009-9070-9","article-title":"Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30","volume":"17","author":"Gal","year":"2010","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.24230","article-title":"Tau reduction prevents disease in a mouse model of Dravet syndrome","volume":"76","author":"Gheyara","year":"2014","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.nbd.2015.03.015_bb0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/156720510793611628","article-title":"Tau pathology and future therapeutics","volume":"7","author":"Gozes","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","article-title":"Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain","volume":"62","author":"Guo","year":"2013","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.03.015_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2013.00034","article-title":"A delicate balance: iron metabolism and diseases of the brain","volume":"5","author":"Hare","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2015.03.015_bb0105","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.03.015_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2009.08.043","article-title":"Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease","volume":"1297","author":"Kaur","year":"2009","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.410260308","article-title":"Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment","volume":"26","author":"Kosik","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.03.015_bb0270","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2011.03.040","article-title":"Novel molecular targets of the neuroprotective\/neurorescue multimodal iron chelating drug M30 in the mouse brain","volume":"189","author":"Kupershmidt","year":"2011","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.nbd.2015.03.015_bb0200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/ars.2011.4279","article-title":"The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease","volume":"17","author":"Kupershmidt","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.nbd.2015.03.015_bb0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2015.03.015_bb0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: relevance to Parkinson's disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces Parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-9-29","article-title":"Motor and cognitive deficits in aged tau knockout mice in two background strains","volume":"9","author":"Lei","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0155","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3233\/JAD-2010-100024","article-title":"The metal chelating and chaperoning effects of clioquinol: insights from yeast studies","volume":"21","author":"Li","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"21","key":"10.1016\/j.nbd.2015.03.015_bb0075","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.3439-13.2014","article-title":"Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging","volume":"34","author":"Ma","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.nbd.2015.03.015_bb0085","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2012.12.003","article-title":"Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice","volume":"34","author":"Morris","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"7723","key":"10.1016\/j.nbd.2015.03.015_bb0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0140-6736(71)90436-3","article-title":"Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey","volume":"2","author":"Nakae","year":"1971","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.nbd.2015.03.015_bb0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"issue":"33","key":"10.1016\/j.nbd.2015.03.015_bb0120","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.physbeh.2005.09.002","article-title":"The use of behavioral test batteries, II: effect of test interval","volume":"87","author":"Paylor","year":"2006","journal-title":"Physiol. Behav."},{"issue":"12","key":"10.1016\/j.nbd.2015.03.015_bb0150","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2015.03.015_bb0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-4159.2004.02496.x","article-title":"Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra","volume":"90","author":"Salvatore","year":"2004","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.nbd.2015.03.015_bb0115","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1074\/jbc.M111.308668","article-title":"Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms","volume":"287","author":"Tardiff","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1074\/jbc.M807579200","article-title":"The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.nbd.2015.03.015_bb0290","doi-asserted-by":"crossref","first-page":"e114174","DOI":"10.1371\/journal.pone.0114174","article-title":"beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.nbd.2015.03.015_bb0295","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.bbagen.2014.08.006","article-title":"A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe under physiologically relevant conditions","volume":"1840","author":"Wong","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2015.03.015_bb0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.11.051","article-title":"Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice","volume":"259","author":"Yabuki","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20081421","article-title":"Clioquinol targets zinc to lysosomes in human cancer cells","volume":"417","author":"Yu","year":"2009","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.nbd.2015.03.015_bb0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition","volume":"95","author":"Zheng","year":"2005","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.nbd.2015.03.015_bb0195","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bmc.2004.10.037","article-title":"Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases","volume":"13","author":"Zheng","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.nbd.2015.03.015_bb0235","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2009.09.024","article-title":"Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration","volume":"37","author":"Zhu","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2015.03.015_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3","article-title":"Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia","volume":"49","author":"Zhukareva","year":"2001","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611500087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611500087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T21:58:51Z","timestamp":1651615131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611500087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":61,"alternative-id":["S096999611500087X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.03.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}